Sera Prognostics, Inc.

SERA Nasdaq SEC CIK 1534969
Follow Sera Prognostics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $42K +162.5% vs same quarter last year
Net income −$8.1M −3.1% vs same quarter last year
EPS, diluted −$0.16 +0% vs same quarter last year
Operating cash flow −$7.3M −12.7% vs same quarter last year
Revenue by quarter
$24K
$38K
$17K
$16K
$10K
$14K
$30K
$42K
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−$60M−$40M−$20M$0$20MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$81K−$31.9M
FY24$77K−$32.9M
FY23$306K−$36.2M
FY22$268K−$44.2M
FY21$82K−$35M
FY20$25K−$19.8M
FY19--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−80000%−60000%−40000%−20000%0%20000%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25−102.5%−45066.7%−39417.3%
FY24−6.5%−47577.9%−42724.7%
FY2331.4%−13013.4%−11843.8%
FY22-−17034.3%−16487.3%
FY21-−43164.6%−42693.9%
FY20-−71884%−79392%
FY19---
Free cash flowOperating cash flow minus capital expenditure
−$40M−$30M−$20M−$10M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$26.3M
FY24−$14.2M
FY23−$27.3M
FY22−$35.4M
FY21−$32.9M
FY20−$17M
FY19-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Sera Prognostics
  • Healthcare median
−80000%−60000%−40000%−20000%0%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearSera PrognosticsHealthcare median
FY25−39417.3%−30.6%
FY24−42724.7%−47%
FY23−11843.8%−58%
FY22−16487.3%−80.4%
FY21−42693.9%−71.8%
FY20−79392%−62.2%
FY19-−46.2%